[ Inscrivez-vous ]
A LA UNE !
20 Novembre 2020
Geneva, Switzerland, 20 novembre (Infosplusgabon) - An advisory body of the UN health agency is not recommending the use of the high-profile antiviral drug Remdesivir for hospitalised COVID-19 patients, saying on Thursday there is insufficient evidence that it improves survival outcomes or cuts down on the need for patients to be put onto ventilators.
Plus d'articles...
- Niger: AfDB grants US$35m to ensure food security for 1.5 million people in rural areas
- Mo Ibrahim Foundation warns against violent elections in Africa
- Amnesty International decries alarming series of executions in Botswana
- Coronavirus: Pandemic robs children in poor countries of nearly four months of school